美容护理行业周报：韩束“超频X肽系列”发布

Investment Rating - The industry investment rating is "Neutral" [25] Core Insights - The beauty and personal care sector outperformed the market, with the Shenwan Beauty Care Index rising by 4.19% while the CSI 300 Index fell by 0.17%, resulting in a 4.36 percentage point outperformance [6][11] - Key companies reported varied performance, with Proya achieving a revenue of 5.001 billion yuan, a year-on-year increase of 37.90%, and a net profit of 702 million yuan, up 40.48% [6][18] - The launch of Han's "Super Frequency X Peptide Series" marks a significant innovation in anti-aging products, utilizing a new composite peptide technology [6][17] Market Performance - The Shenwan Beauty Care Index increased by 4.19% this week, while the CSI 300 Index decreased by 0.17%, making it the fourth-best performing sector among all Shenwan primary industries [11][12] - The top five performing stocks in the sector included Proya (+12.35%), Runben (+11.30%), and Yanjing (+10.50%) [6][14] Company Announcements - Proya's half-year results showed a revenue of 5.001 billion yuan and a net profit of 702 million yuan, reflecting strong growth [6][18] - The launch of Han's "Super Frequency X Peptide Series" aims to enhance anti-aging effects by activating collagen cells and improving skin texture [6][17] Consumer Trends - The cosmetics market is experiencing a shift towards more rational consumer spending, with domestic brands like Proya gaining market share [7] - The medical beauty sector is seeing dual growth in supply and demand, with increasing compliance and domestic substitution rates [7] Data Tracking - In July 2024, the total retail sales of consumer goods in China reached 37.757 billion yuan, with cosmetic retail sales declining by 6.1% year-on-year [20]